Amlodipine/valsartan 5/160 mg versus valsartan 160 mg in Chinese hypertensives

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 2024-2030

  Zhu, Dingliang ^a   Yang, Kan ^b   Sun, Ningling ^c   Gao, Pingjin ^a   Wang, Ruonan ^d   Grosso, Amie ^e   Zhang, Ying ^e  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^d Beijing SL Pharmaceutical Co Ltd   (China)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

5 160 mg; Amlodipine; Chinese; Hypertensives; Single pill combination; Valsartan

Indexed keywords

AMLODIPINE PLUS VALSARTAN; VALSARTAN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FLANK PAIN; HUMAN; HYPERTENSION; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

5/160MG; AMLODIPINE; CHINESE; HYPERTENSIVES; SINGLE-PILL COMBINATION; VALSARTAN;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TETRAZOLES; VALINE;

EID: 84883261407     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.039     Document Type: Article

References (38)

1. Y. Wu, R. Huxley, and L. Li Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002 Circulation 118 2008 2679 2686
2. Z. Sun, L. Zheng, and C. Xu Prevalence of prehypertension, hypertension and, associated risk factors in Mongolian and Han Chinese populations in Northeast China Int J Cardiol 128 2008 250 254
3. T. Xu, Y. Wang, and W. Li Survey of prevalence, awareness, treatment, and control of hypertension among Chinese governmental and institutional employees in Beijing Clin Cardiol 33 2010 E66 E72
4. US Dept of State Background note: China Available at: www.state.gov/r/pa/ei/bgn/18902.htm 2011 Accessed June 16, 2011
5. T.N. Kelly, D. Gu, and J. Chen Hypertension subtype and risk of cardiovascular disease in Chinese adults Circulation 118 2008 1558 1566
6. Y. Zhang, X. Zhang, L. Liu, and A. Zanchetti Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study J Hypertens 28 2010 2016 2025
7. J. He, D. Gu, and J. Chen Premature deaths attributable to blood pressure in China: a prospective cohort study Lancet 374 2009 1765 1772
8. D. Gu, J. Chen, and X. Wu Prehypertension and risk of cardiovascular disease in Chinese adults J Hypertens 27 2009 721 729
9. J. He, D. Gu, and X. Wu Major causes of death among men and women in China N Engl J Med 353 2005 1124 1134
10. A.V. Chobanian, G.L. Bakris, and H.R. Black Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 2003 1206 1252
11. G. Mancia, S. Laurent, and E. Agabiti-Rosei Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens 27 2009 2121 2158
12. L.S. Liu 2010 Chinese guidelines for the management of hypertension Zhonghua Xin Xue Guan Bing Za Zhi 39 2011 579 615
13. A.H. Gradman, J.N. Basile, B.L. Carter, and G.L. Bakris Combination therapy in hypertension J Am Soc Hypertens 4 2010 42 50
14. J. Huang, N.L. Sun, and Y.M. Hao Efficacy and tolerability of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients not adequately controlled with valsartan monotherapy Clin Exp Hypertens 33 2011 179 186
15. Y. Ke, D. Zhu, and H. Hong Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy Curr Med Res Opin 26 2010 1705 1713
16. M.C. Wong Comparing the cumulative incidences of add-on therapy among the major antihypertensive classes in 2531 Asian patients: a cohort study J Clin Pharm Ther 35 2010 201 205
17. J.G. Wang, J.A. Staessen, L. Gong, and L. Liu Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group Arch Intern Med 160 2000 211 220
18. L. Gong, W. Zhang, and Y. Zhu Shanghai trial of nifedipine in the elderly (STONE) J Hypertens 14 1996 1237 1245
19. L. Liu, Y. Zhang, G. Liu, W. Li, X. Zhang, and A. Zanchetti The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients J Hypertens 23 2005 2157 2172
20. Exforge (amlodipine and valsartan) tablets [prescribing information] 2009 Novartis Pharmaceuticals Corporation
21. MIMS (Hong Kong) Exforge® 5/80 mg film coated tab Available at: www.mims.com 2011 Accessed April 12, 2011
22. D. Perloff, C. Grim, and J. Flack Human blood pressure determination by sphygmomanometry Circulation 88 1993 2460 2470
23. T.G. Pickering, J.E. Hall, and L.J. Appel Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Hypertension 45 2005 142 161
24. Y. Allemann, B. Fraile, M. Lambert, M. Barbier, P. Ferber, and J.L. Izzo Jr. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study J Clin Hypertens (Greenwich) 10 2008 185 194
25. W. Sinkiewicz, R.D. Glazer, and A. Kavoliuniene Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy Curr Med Res Opin 25 2009 315 324
26. G. Dwivedi, and D.G. Beevers Hypertension in ethnic groups: epidemiological and clinical perspectives Expert Rev Cardiovasc Ther 7 2009 955 963
27. H. Makani, S. Bangalore, and J. Romero Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate - a meta-analysis of randomized trials J Hypertens 29 2011 1270 1280
28. H. Makani, S. Bangalore, J. Romero, O. Wever-Pinzon, and F.H. Messerli Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Am J Med 124 2011 128 135
29. B. Waeber, and L.M. Ruilope Amlodipine and valsartan as components of a rational and effective fixed-dose combination Vasc Health Risk Manag 5 2009 165 174
30. H. Schunkert, R.D. Glazer, and M. Wernsing Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy Curr Med Res Opin 25 2009 2655 2662
31. Norvasc® (amlodipine besylate) tablets [prescribing information] 2011 Pfizer Labs New York, NY
32. J. Li, and H. Wang The poor control of hypertension in China Afr J Biotechnol 9 2010 8241 8242
33. L. Breitscheidel, B. Ehlken, K. Kostev, M.S. Oberdiek, A. Sandberg, and R.E. Schmieder Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany J Med Econ 15 2012 155 165
34. M.A. Malesker, and D.E. Hilleman Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy Manag Care 19 2010 36 42
35. M. Dickson, and C.A. Plauschinat Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy Am J Cardiovasc Drugs 8 2008 45 50
36. A.A. Taylor, and O. Shoheiber Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy Congest Heart Fail 9 2003 324 332
37. M.C. Wong, J.Y. Jiang, and S.M. Griffiths Adherence to combination therapy among ethnic Chinese patients: a cohort study Hypertens Res 33 2010 416 421
38. T. Philipp, T.R. Smith, and R. Glazer Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension Clin Ther 29 2007 563 580